Schedule 13G ownership disclosure
Ultragenyx Pharmaceutical Inc
Security class unavailable · CUSIP: 90400D108
Event date: 2022-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,711,517
- Percent of class
- 2.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-22-000126
- Form type
- SC 13G
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- Dec 09, 2022
- Reporting period
- Nov 30, 2022
- Description
- Schedule 13G beneficial ownership